Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Healthcare Industry News Australian Medtech firm EMVision unveils backpack-sized brain scanner for first responders EMVision Medical Devices Limited (ASX: EMV), an innovative Australian medical device company, has announced its groundbreaking First Responder… byPallavi MadhirajuJuly 23, 2024